Showing results (611-620 of 651) with videos related to
Sort By:
Pageof 66
Nature Cancer|January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trialStephen J Bagley, Zev A Binder, Lamia Lamrani, et al.Nature Cancer|March 23, 2024
Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogrammingXujia Wu, Huairui Yuan, Qiulian Wu, et al.Nature Cancer|March 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapiesAnton Dobrin, Pieter L Lindenbergh, Yuzhe Shi, et al.Nature Cancer|September 20, 2024
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual diseaseLea Lemaitre, Nia Adeniji, Akanksha Suresh, et al.Nature Cancer|September 17, 2024
Vascular heterogeneity of tight junction Claudins guides organotropic metastasisXunian Zhou, Valerie S LeBleu, Eliot Fletcher-Sananikone, et al.Nature Cancer|September 17, 2024
Targeting therapy-persistent residual diseaseXiaoxiao Sun, Lani F Wu, Steven J Altschuler, et al.Nature Cancer|March 1, 2024
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsOren Barboy, Akhiad Bercovich, Hanjie Li, et al.Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.Nature Cancer|July 24, 2023
Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancerXiaocui Zheng, Xinjing Wang, Xi Cheng, et al.Nature Cancer|July 25, 2023
Leveraging translational insights toward precision medicine approaches for brain metastasesAlbert E Kim, Edwin Nieblas-Bedolla, Magali A de Sauvage, et al.Pageof 66